Wilson's Disease.

Turning tumor-promoting copper into an anti-cancer weapon via high-throughput chemistry. Curr Med Chem (2010) 0.83

Penicillamine, a new oral therapy for Wilson's disease. Am J Med (1956) 3.68

Wilson disease. Medicine (Baltimore) (1992) 2.22

Prevention of Wilson's disease in asymptomatic patients. N Engl J Med (1968) 2.11

Initial therapy of patients with Wilson's disease with tetrathiomolybdate. Arch Neurol (1991) 1.53

Treatment of Wilson's disease with ammonium tetrathiomolybdate. I. Initial therapy in 17 neurologically affected patients. Arch Neurol (1994) 1.51

Treatment of Wilson's disease with zinc: XV long-term follow-up studies. J Lab Clin Med (1998) 1.40

Treatment of Wilson's disease with trientine (triethylene tetramine) dihydrochloride. Lancet (1982) 1.36

Worsening of neurologic syndrome in patients with Wilson's disease with initial penicillamine therapy. Arch Neurol (1987) 1.28

Wilson's disease: clinical presentation and use of prognostic index. Gut (1986) 1.16

Congenital connective-tissue defect probably due to D-penicillamine treatment in pregnancy. Lancet (1971) 1.06

Treatment of Wilson's disease with zinc: X. Intestinal metallothionein induction. J Lab Clin Med (1992) 0.91

Treatment of Wilson disease with ammonium tetrathiomolybdate. II. Initial therapy in 33 neurologically affected patients and follow-up with zinc therapy. Arch Neurol (1996) 0.91

Treatment of Wilson's disease with zinc. XIII: Therapy with zinc in presymptomatic patients from the time of diagnosis. J Lab Clin Med (1994) 0.82

Neonatal abnormalities associated with D-penicillamine treatment during pregnancy. N Engl J Med (1977) 0.78